A comparison of intravenous pulse methylprednisolone and dexamethasone on idiopathic sudden sensorineural hearing loss : A double-blind randomized controlled trial

Phase 4

Recruiting

• Conditions: idiopathic sudden sensorineural hearing loss; Idiopathic sudden sensorineural hearing loss, steroid, intravenous pulse; methylprednisolone, intravenous dexamethasone

• Registration Number: TCTR20211224004
• Lead Sponsor: Sirinkarn Sookdee

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-12-22
• Study Start: 2021-12-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Unilatearal sudden sensorineural hearing loss <= 14days 2.Audiogram shows Pure Tone Average :PTA > 30 bD at least 3 frequency

Exclusion Criteria

1. no stroke/brain tumor 2.no history of ear/head truama 3. no history of ototoxic drug use 4.no history of loud noise exposure 5. no history of ear infection 6. no history of steroid use within 1 month 7. no history of steroid allergy/ immunocompromised host/ DM 8.no history of GI bleeding 9. no pregnancy or breast feeding

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recovery level 3day,10day,17day Audiogram

Secondary Outcome Measures

Name	Time	Method
Side effect 3day,10day,17day Questionaire